Your session is about to expire
← Back to Search
Subcutaneous Lenacapavir for HIV (CALIBRATE Trial)
CALIBRATE Trial Summary
This trial will study whether lenacapavir can effectively treat HIV in people who already have the virus.
CALIBRATE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CALIBRATE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research require additional participants?
"The trial information found on clinicaltrials.gov indicates that this research is not seeking any fresh participants; the listing, which was initially posted on November 22nd 2019 and last updated April 20th 2022, has been put in pause for now. Luckily, 207 other trials are still recruiting patients at present."
Has Subcutaneous Lenacapavir been granted approval by the FDA?
"Lenacapavir's safety was assessed at a 2 due to existing Phase Two data which attests to its security but lacks any evidence of it efficacy."
What conditions is Subcutaneous Lenacapavir most commonly prescribed for?
"Subcutaneous Lenacapavir is the go-to medication for anti-retroviral agents. It has also been known to treat HIV-1 and patients with no resistance to darunavir who have not begun treatment yet."
How many participants are eligible to partake in this investigation?
"This clinical trial has ceased recruitment, having been initially posted on November 22nd 2019 and the last update dated April 20th 2022. If you are still seeking to participate in a medical study, 107 trials for human immunodeficiency virus type 1 (hiv-1) infection and 100 studies related to Subcutaneous Lenacapavir are currently recruiting patients."
Are there any earlier clinical experiments that employed Subcutaneous Lenacapavir?
"Lenacapavir was first researched in 2002 at the University of Zurich, with 360 studies completed to date. Currently, there are 100 clinical trials actively underway - a substantial amount based out of Washington D.C.."
Are there various sites in the city that are currently conducting this clinical trial?
"This clinical trail has recruited 49 medical institutions to participate, such as Whitman-Walker Institute, Inc. in Washington, St. Jude Children's Research Hospital in Memphis and KC CARE Health Center in Kansas City."
Share this study with friends
Copy Link
Messenger